Neogen Corporation (NEOG) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $9.61. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of NEOG = $2.63 (-72.6% from the current price, the stock appears overvalued). Analyst consensus target is NEOG = $11 (+14.5% upside).
Valuation: NEOG trades at a trailing Price-to-Earnings (P/E) of -3.8 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.15.
Financials: revenue is $895M, +21.7%/yr average growth. Net income is $1.1B (loss), growing at -3860%/yr. Net profit margin is -122.1% (negative). Gross margin is 47.1% (+1 pp trend).
Balance sheet: total debt is $913M against $2.1B equity (Debt-to-Equity (D/E) ratio 0.44, conservative). Current ratio is 3.32 (strong liquidity). Debt-to-assets is 26.5%. Total assets: $3.4B.
Analyst outlook: 4 / 11 analysts rate NEOG as buy (36%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 56/100 (Partial), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 59/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).
